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This article is a comment on: Endurance, aerobic high-intensity, and 
repeated sprint cycling performance is unaffected by normobaric “Live 
High-Train Low”: a double-blind placebo-controlled cross-over study, 
by Bejder J, Andersen AB, Buchardt R, Larsson TH, Olsen NV, 
Nordsborg NB. Eur J Appl Physiol (2017) 117:979–988.
AQ1
We read with attention the article by Bejder et al. (2017). While we 
acknowledge the good intent of the authors to carefully follow scientific 
gold-standard design of a double-blind, placebo-controlled, cross-over 
trial, we were disappointed that the general recommendations (i.e., 
>12 h day  at simulated altitude ranging 2000–2500 m for 3–4 weeks) 
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for “live high-train low” (LHTL) altitude strategy (Chapman et al. 
2014) were not respected. Subsequently, one may have been surprised 
to observe any LHTL putative effects. Even though Bejder et al. (2017) 
extensively discuss several potential limitations (see Methodological 
considerations section), several other boundaries (i.e., unsuitable 
hypoxic dose, normobaric hypoxic tent discomfort, inadequate training 
intensity distribution) may have, alone or in combination, altered the 
outcomes of their study.
AQ2
AQ3
To compensate the restricted low daily hypoxic dose (i.e., 8 h day ) 
due to the use of normobaric hypoxic tents, Bejder et al. (2017) 
extended the duration of intervention (i.e., 6 weeks) and increased the 
altitude level (i.e., 3 × 2 weeks at 2500, 3000, and 3500 m, 
respectively), resulting to a total hypoxic dose of 336 h (or 1008 km h
using the new km h  hypoxic metrics) expected to induce the 
erythropoietic cascade and improve exercise performance. However, it 
seems that hypoxic severity and/or intervention duration were 
inadequate. For instance, hypoxic stress >3000 m was suggested to be 
detrimental to acclimatization (Brugniaux et al. 2006) and sea-level 
performance enhancement (Chapman et al. 2014). The most likely 
explanation relates to an accumulated influence of negative factors. In 
particular, the use of the (commercially available) normobaric hypoxic 
tent could have contributed to respiratory disturbance, with increases in 
sleep apneas (Pedlar et al. 2005), via an accumulation of expired carbon 
dioxide (CO ), as well as a rise in temperature and humidity inside the 
tent. Alone or in combination with the hypoxic stress, hypercapnia 
might have induced neurocognitive deficits (i.e., acute changes in 
cerebral blood flow, pH, catecholamine, and neuronal excitability) and 
depression in cortical electrical activity, related to endocrine and 
cardiovascular alterations (see viewpoint and comments from Wang et 
al. 2016). Therefore, when using such low air volume material, CO
monitoring must be encouraged (in addition to desaturation-level 
control, which was not the case in Bejder et al. 2017). While the long-
term health implications of sleep apneas in athletes remain unknown, 
inadequate restorative process between training sessions may lead to 
symptoms of overreaching or overtraining (Pedlar et al. 2005).
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Regarding training intensity distribution, careful analysis of weekly 
average time spent at low, moderate, and high intensities during sport-
specific training (see Table 1 in Bejder et al. 2017) indicates an 
inadequate balance when compared to the current practice in endurance 
sports (Tonnessen et al. 2014): with an averaged total training time of 
~16–20 h per week for supposed highly trained triathletes (body weight 
of ~80 kg), approximately half of the time was allocated for moderate- 
(i.e., ~33–34%) and high-intensity (i.e., ~12–13%) training, 
respectively. Such training intensity distribution differs from the 
polarized training model (i.e., ~75–80% at low intensity, ~5–10% at 
moderate intensity, and ~15–20% at high intensity) generally adopted 
by endurance athletes and may have participated to inappropriate level 
of training stress (Tonnessen et al. 2014). The lack of fatigue 
monitoring as recommended with elite athletes (Schmitt et al. 2015) 
could explain the slightly reduced maximum physical capacity (i.e., 
incremental peak power output measured after LHTL intervention). 
Therefore, to secure optimal adaptation and counteract unwanted side 
effects such as overreaching/overtraining symptoms, cautious training 
loads monitoring should be implemented.
Hence, while it seems difficult to decipher on the effectiveness of 
LHTL paradigm in the study by Bejder et al. (2017), it is clearly evident 
that the selection of basic components such as appropriate hypoxic dose 
and proper training load and fatigue management appear paramount to 
success with LHTL’s method.
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